Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 8, 2009, doi:10.1212/WNL.0b013e3181b01077)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 73, Number 9, September 1, 2009
Right arrow Podcast
Right arrow All Versions of this Article:
WNL.0b013e3181b01077v1
73/9/665    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Iacono, D.
Right arrow Articles by Troncoso, J. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iacono, D.
Right arrow Articles by Troncoso, J. C.
Related Collections
Right arrow Alzheimer's disease
Right arrow Assessment of cognitive disorders/dementia
Right arrowRelated Article
NEUROLOGY 2009;73:665-673
© 2009 American Academy of Neurology

The Nun Study

Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life

D. Iacono, MD, PhD, W. R. Markesbery, MD, M. Gross, PhD, O. Pletnikova, MD, G. Rudow, BS, P. Zandi, PhD and J. C. Troncoso, MD

From the Departments of Pathology (D.I., O.P., G.R., J.C.T.), Division of Neuropathology, Neurology (J.C.T.), and Mental Health (P.Z.), Johns Hopkins University, Baltimore, MD; Departments of Pathology, Neurology, and Alzheimer’s Disease Center (W.R.M.), Sanders-Brown Center on Aging, University of Kentucky, Lexington; and Department of Laboratory Medicine and Pathology (M.G.), University of Minnesota, Minneapolis.

Address correspondence and reprint requests to Dr. Juan C. Troncoso, Division of Neuropathology, Department of Pathology, Johns Hopkins University, School of Medicine, Ross Building 558, 720 Rutland Avenue, Baltimore, MD 21205 troncoso{at}jhmi.edu

Background: It is common to find substantial Alzheimer disease (AD) lesions, i.e., neuritic β-amyloid plaques and neurofibrillary tangles, in the autopsied brains of elderly subjects with normal cognition assessed shortly before death. We have termed this status asymptomatic AD (ASYMAD). We assessed the morphologic substrate of ASYMAD compared to mild cognitive impairment (MCI) in subjects from the Nun Study. In addition, possible correlations between linguistic abilities in early life and the presence of AD pathology with and without clinical manifestations in late life were considered.

Methods: Design-based stereology was used to measure the volumes of neuronal cell bodies, nuclei, and nucleoli in the CA1 region of hippocampus (CA1). Four groups of subjects were compared: ASYMAD (n = 10), MCI (n = 5), AD (n = 10), and age-matched controls (n = 13). Linguistic ability assessed in early life was compared among all groups.

Results: A significant hypertrophy of the cell bodies (+44.9%), nuclei (+59.7%), and nucleoli (+80.2%) in the CA1 neurons was found in ASYMAD compared with MCI. Similar differences were observed with controls. Furthermore, significant higher idea density scores in early life were observed in controls and ASYMAD group compared to MCI and AD groups.

Conclusions: 1) Neuronal hypertrophy may constitute an early cellular response to Alzheimer disease (AD) pathology or reflect compensatory mechanisms that prevent cognitive impairment despite substantial AD lesions; 2) higher idea density scores in early life are associated with intact cognition in late life despite the presence of AD lesions.

Abbreviations: ACG = anterior cingulate gyrus; AD = Alzheimer disease; ADL = activities of daily living; ASYMAD = asymptomatic Alzheimer disease; BLSA = Baltimore Longitudinal Study of Aging; CERAD = Consortium to Establish a Registry for Alzheimer’s Disease; H-E = hematoxylin-eosin; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; NFT = neurofibrillary tangles; NP = neuritic plaques; PCG = posterior cingulate gyrus; PVC = primary visual cortex.


Editorial, page 656

e-Pub ahead of print on July 8, 2009, at www.neurology.org.

Supported by the Johns Hopkins University Alzheimer’s Disease Research Center (NIH grant P50AG05146), the Nun Study (NIA grants: R01AG09862, K04AG00553), the University of Kentucky Alzheimer’s Disease Center (NIH grant AG028383), the Abercrombie Foundation, and the Kleberg Foundation.

Disclosure: The authors report no disclosures.

Received November 25, 2008. Accepted in final form May 11, 2009.


Related Article

Compensating for Alzheimer lesions: Evidence that size counts
Carol F. Lippa
Neurology 2009 73: 656-657. [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeurologyHome page
C. F. Lippa
Compensating for Alzheimer lesions: Evidence that size counts
Neurology, September 1, 2009; 73(9): 656 - 657.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.